|
Tocris
oxr2 antagonist tcs ox2 29 ![]() Oxr2 Antagonist Tcs Ox2 29, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/oxr2 antagonist tcs ox2 29/product/Tocris Average 95 stars, based on 1 article reviews
oxr2 antagonist tcs ox2 29 - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
tcs ox2 ![]() Tcs Ox2, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tcs ox2/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
tcs ox2 - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
Tocris
tcsox229 ![]() Tcsox229, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tcsox229/product/Tocris Average 93 stars, based on 1 article reviews
tcsox229 - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
Banyu Pharmaceutical
selective ox1 receptor antagonist tcs ox2 29 ![]() Selective Ox1 Receptor Antagonist Tcs Ox2 29, supplied by Banyu Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/selective ox1 receptor antagonist tcs ox2 29/product/Banyu Pharmaceutical Average 90 stars, based on 1 article reviews
selective ox1 receptor antagonist tcs ox2 29 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
FUJIFILM
tcs-ox2-29 (tcs ![]() Tcs Ox2 29 (Tcs, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tcs-ox2-29 (tcs/product/FUJIFILM Average 90 stars, based on 1 article reviews
tcs-ox2-29 (tcs - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
CH Instruments
tcs-ox2-29 ![]() Tcs Ox2 29, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tcs-ox2-29/product/CH Instruments Average 90 stars, based on 1 article reviews
tcs-ox2-29 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
TCS-OX2-29, also known as TCSOX229, is a selective OX2 receptor antagonist (IC50 = 40 nM, pKi = 7.5) with >250-fold selectivity for hOX2R compared with hOX1R (IC50s = 40 nM and >10,000 nM, respectively) and
|
Buy from Supplier |
|
TCS-OX2-29 is a potent, high affinities and selective orexin-2 receptor (OX2R) antagonist with an IC50 value of 40 nM and a pKI value of 7.5. TCS-OX2-29 displays ~250-fold selectivity for OX2 over OX1.
|
Buy from Supplier |
|
Store at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months.
|
Buy from Supplier |
Image Search Results
Journal: Neurobiology of Stress
Article Title: Lateral hypothalamus orexinergic inputs to lateral habenula modulate maladaptation after social defeat stress
doi: 10.1016/j.ynstr.2021.100298
Figure Lengend Snippet: Activation of the LHA Orx -LHb Glu circuit after social defeat stress ( a ) Experimental design of the FosTRAP strategy. ( b ) Representative tdTomato expression in the LHA (top) and LHb (bottom) of nondefeated and defeated mice. ( c ) Quantification of Fos-positive cells in the LHA (top, 129.9 ± 6.877 vs. 220.4 ± 10.77, t = 7.080, p < 0.0001) and LHb (bottom, 52.40 ± 3.879 vs. 134.1 ± 6.993, t = 10.22, p < 0.0001) of non-defeated and defeated mice. ( d ) Representative overlap of tdTomato expression with neurons expressing glutamate (left), OxR2 (middle), and GAD2 (right) in the LHb of non-defeated (top) and defeated (bottom) mice. ( e ) Percentage of Fos-positive neurons in neurons expressing glutamate (left, 4.896 ± 0.3217% vs. 75.25 ± 1.751%, t = 39.52, p < 0.0001), OxR2 (middle, 28.50 ± 0.8929% vs. 79.76 ± 2.069%, t = 22.75, p < 0.0001), and GAD2 (right, 59.32 ± 1.829% vs. 47.99 ± 2.241%, t = 3.917, p = 0.0012) in non-defeated and defeated mice. ( f ) Representative overlap of tdTomato expression with the neurons expressing orexin A (OA) in the LHA of non-defeated (top) and defeated (bottom) mice. ( g ) Percentage of Fos-positive neurons in the OA-expressing neurons (27.07 ± 1.968% vs. 76.05 ± 1.905%, t = 17.88, p < 0.0001) of nondefeated and defeated mice. ( h ) Representative overlap of the neurons expressing glutamate and OxR2 in the LHb. ( i ) Percentage of glutamate expression among OxR2-positive neurons (49.74 ± 2.970%) and OxR2 expression among glutamate positive neurons (32.15 ± 2.689%). Data are presented as mean ± standard error of the mean. *p < 0.05, **p < 0.01, and ***p < 0.001 (unpaired t -test). LHA, lateral hypothalamic area; LHb, lateral habenula.
Article Snippet: Orexin-A (Tocris Bioscience, USA) were dissolved in saline at a concentration of 333 pmol/μL, and the
Techniques: Activation Assay, Expressing
Journal: Neurobiology of Stress
Article Title: Lateral hypothalamus orexinergic inputs to lateral habenula modulate maladaptation after social defeat stress
doi: 10.1016/j.ynstr.2021.100298
Figure Lengend Snippet: Infusion of OxR2 antagonist into the LHb exacerbated social avoidance and depressive behaviors after chronic social defeat stress ( a ) Representative trajectories in the social interaction tests of susceptible mice with administration of vehicle (left) or TCS-OX2-29 (right) into the LHb. ( b ) Infusion of TCS-OX2-29 into the LHb did not affect the social interaction ratios in the interaction zone (left, 0.6843 ± 0.07429 vs. 0.5095 ± 0.08592, t = 1.538, p = 0.1463) but increased the ratio in the corner zone (right, 0.8814 ± 0.2580 vs. 1.844 ± 0.2147, t = 2.869, p = 0.0124). Infusion of TCS-OX2-29 reduced the ( c ) total travel distance in the social interaction test (7.827 ± 0.8908m vs. 4.840 ± 0.7645m, t = 2.545, p = 0.0234), but did not increase ( d ) travel distance in the interaction zone (1.414 ± 0.1901m vs. 1.136 ± 0.1188m, t = 1.238, p = 0.2361) or ( e ) corner zone (1.143 ± 0.1699m vs. 0.9391 ± 0.1808m, t = 0.8227, p = 0.4245). Infusion of TCS-OX2-29 increased the ( f ) percentage of time spent immobile in the tail suspension test (52.86 ± 1.988% vs. 60.31 ± 1.356%, t = 3.095, p = 0.0079) and ( g ) percentage of time spent immobile in the forced swimming test (24.71 ± 1.967% vs. 33.91 ± 1.362%, t = 3.577, p = 0.0038). Data are presented as the mean ± SEM. *p < 0.05, **p < 0.01 (unpaired t -test). LHb, lateral habenula.
Article Snippet: Orexin-A (Tocris Bioscience, USA) were dissolved in saline at a concentration of 333 pmol/μL, and the
Techniques: Suspension